Fresenius Medical Care AG & Co. KGaA

Investor Presentation • Nov 30, 2010

Corporate Profile

Fresenius Medical Care

Fresenius Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1,890,000 individuals worldwide. Through its network of 2,716 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to 210,191 patients around the globe. Fresenius Medical Care also is the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products.

Growth Strategy

GOAL 10…

…is the name of Fresenius Medical Care's strategy adopted by 2005 for sustained growth until 2010. In order to achieve revenues of US-\$ 12 billion in 2010 in conjunction with an annual revenue growth of 7 - 9% based on constant currencies and an annual 10% increase in net income, GOAL 10 defines four strategic paths:

• Organic growth in dialysis services by innovative treatment techniques and the opening of new clinics
• Acquisitions of existing clinics to ensure optimized international presence
• Horizontal expansion in the sector of Renal Drugs as well as
• A boosted activity in home therapies

Key Figures - Summary Third Quarter 2010

Net revenue	US-\$	3,058 million	+ 6%
Operating income (EBIT)	US-\$	493 million	+ 9%
Net income attributable to Fresenius Medical Care AG & Co. KGaA	US-\$	248 million	+ 10%
Earnings per share	US-\$	0.82	+ 9%
Total assets1)	US-\$	16,696 million
Operating Cash flow	US-\$	384 million
Employees1)		72,812
Patients1)		210,191	+ 9%
Clinics1)		2,716	+ 8%
Treatments2)		23,41 million	+ 7%
1) as of September 30, 2010

2) first nine months of 2010

Revenue Q3 2010 per region (US\$ 3,058 m)

Goals for 2010

Net revenue	>US-\$ 12.0 billion
Net income	US-\$ 960-980 million
Leverage Ratio (Debt/EBITDA)	< 2.5
Capital Expenditures	US-\$ 550-650 million
Acquisitions	up to US-\$ 500 million

Management Board Supervisory Board

• Dr. Ben J. Lipps (Chairman) Dr. Gerd Krick (Chairman)

• Kent Wanzek

• Rice Powell (Vice Chairman) Dr. Dieter Schenk (Vice Chairman)

• Michael Brosnan Dr. Walter L. Weisman
• Roberto Fusté John Gerhard Kringel
• Dr. Emanuele Gatti William P. Johnston
• Dr. Rainer Runte Prof. Dr. Bernd Fahrholz

Share Profile – Key Data

	Ordinary shares	Preference shares
Ticker Symbols
Frankfurt Stock Exchange	FME	FME3
New York Stock Exchange (NYSE)	FMS	FMS/P
Reuters: XETRA / Frankfurt Stock Exchange	FMEG.DE / FMEG.F	FMEG_p.DE / FMEG_p.F
Bloomberg	FME GY	FME3 GY
Security Identification Numbers
WKN	578 580	578 583
ISIN	DE 0005785802	DE 0005785836
CUSIP No. (NYSE)	358029106	358029205

Financing Instruments and Maturity Profile

	Year issued	Amount	Coupon %	Maturity
		in million
Credit Agreement Term Loan A	2006	\$ 1,8501)		March 31, 2013
Credit Agreement Term Loan B	2006	\$ 1,7501)		March 31, 2013
Senior Notes 2010 - 2016	2010	€ 250	5 1/2%	July 15, 2016
Senior Notes 2007 - 2017	2007	\$ 500	6 7/8%	July 15, 2017
Trust Preferred Securities IV	2001	\$ 225	7 7/8%	June 15, 2011
Trust Preferred Securities V	2001	€ 300	7 3/8%	June 15, 2011
Notes (Schuldscheindarlehen)	2009	€ 155		October 27, 2012
Notes (Schuldscheindarlehen)	2009	€ 45		October 27, 2014

1) at the beginning before amortisation and extension

Share Price Development last 12 months Financial Calendar

Capital Structure Contacts

		Event	Date
46,00		Report on Third Quarter
44,00		Earnings Release:	November 2, 2010
42,00		Conference Call:	November 2, 2010
40,00		Deutsche Börse & IFRS Filing:	November 30, 2010
38,00		Report on Full Year 2010:	February 23, 2011
36,00		Report on First Quarter 2011:	May 4, 2011
34,00		Annual General Meeting 2011:	May 12, 2011
32,00 30,00		Report on Second Quarter 2011:	August 2, 2011
	08.11.09 08.02.10 08.05.10 08.08.10 08.11.10	Report on Third Quarter 2011:	November 2, 2011

Fresenius Medical Care AG & Co. KGaA Investor Relations & Corporate Communications Else-Kröner-Straße 1 61352 Bad Homburg
Oliver Maier Senior Vice President, Head of IR & CC	P:+49(0)6172-609-2525 F: +49(0)6172-609-2301
Gerrit Jost Director	P:+49(0)6172-609-5216
North America Terry L. Morris Vice President	P:+1-800-948-2538 F: +1-615-345-5605